SCHEMBL16349

SCHEMBL16349

O=S(=O)(c1ccc(Cl)nc1)N1CCN[C@](CN2C3COCC2CC(O)C3)(c2ncc(C(O)(C(F)(F)F)C(F)(F)F)cn2)C1

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GCK P35557 12/20 0.38
POLB P06746 1/20 0.37
GCKR Q14397 1/20 0.35
RORC P51449 3/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17033 0.92 GCK (0.46) GCKGCKR
SCHEMBL16652 0.92 GCK (0.37) GCKPOLBGCKRRORCALDH1A1
SCHEMBL21749 0.83 RORC (0.39) GCKGCKRRORC
SCHEMBL16486 0.81 GCK (0.30) GCK
SCHEMBL16561 0.80 GCK (0.38) GCKPOLBGCKRRORCALDH1A1
SCHEMBL16348 0.79
SCHEMBL17307 0.79 GCK (0.39) GCKPOLBGCKRRORCALDH1A1
SCHEMBL17107 0.77 GCKR (0.48) GCKGCKR
SCHEMBL16428 0.76
SCHEMBL16127 0.75 GCK (0.34) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed